Pooling of patient samples is commonly used in immunoassays and molecular diagnostics to increase testing capacity while reducing reagent costs for the analysis of SARS-CoV-2 and other infectious ...

With results from COVID-19 tests routinely taking one week or longer to complete, some labs are trying a new approach called sample pooling. The idea is labs can save coveted supplies if they test ...

On June 16, the U.S. Food and Drug Administration (FDA) posted updates to their Molecular Diagnostic Templates for developers that intend their assay to be used for pooled patient samples or for ...

On July 18, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for sample pooling of specimens when using the SARS-CoV-2 rRT-PCR diagnostic test from Quest ...

This article was updated to include new information about LabCorp and Stanford Health Care’s pool testing efforts. As pandemic re-opening efforts show mixed success, across the U.S., there have been ...

WASHINGTON — The Food and Drug Administration has given emergency approval to a new approach to coronavirus testing that combines test samples in batches instead of running them one by one, speeding ...

INTEGRA’s automated pipetting solutions are helping scientists meet the challenge of efficiently pooling potentially infectious samples prior to testing for disease surveillance and diagnostics, ...